Helius Medical Technologies (HSDT) financial statements
Helius Medical Technologies reported revenue of $548,000 in fiscal 2025, up 2.0% a year over 7 years.
Net income was -$41M.
The diluted share count rose 8124% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Helius Medical Technologies's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $478,000 | $1M | $661,000 | $493,000 | $778,000 | $605,000 | $520,000 | $548,000 |
| Cost of revenue | — | — | — | $846,000 | $388,000 | $298,000 | $463,000 | $583,000 | $582,000 | $500,000 |
| Gross profit | — | — | $478,000 | $650,000 | $273,000 | $224,000 | $324,000 | $61,000 | -$62,000 | $6M |
| Research and development | $4M | $14M | $10M | $8M | $5M | $6M | $4M | $3M | $4M | $4M |
| Selling, general and admin | $6M | $8M | $17M | $17M | $10M | $12M | $11M | $9M | $10M | $23M |
| Operating income | -$9M | -$23M | -$27M | -$24M | -$14M | -$18M | -$16M | -$12M | -$14M | -$244M |
| Interest expense | $46,920 | — | — | — | — | — | — | — | — | — |
| Pre-tax income | -$7M | $28M | $29M | $10M | -$14M | -$18M | -$14M | -$9M | -$12M | -$41M |
| Income tax | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$7M | -$28M | -$29M | -$10M | -$14M | -$18M | -$14M | -$9M | -$12M | -$41M |
| EPS (diluted) | -$30.00 | -$75.00 | -$63.00 | -$649.50 | -$590.00 | -$369.00 | -$52.13 | -$14.56 | -$3,282.26 | -$1.85 |
| Diluted shares | 0M | 0M | 0M | 0M | 0M | 0M | 0M | 1M | 0M | 22M |
| Gross margin | — | — | 100.0% | 43.4% | 41.3% | 45.4% | 41.6% | 10.1% | -11.9% | 1006.8% |
| Operating margin | — | — | -5580.5% | -1604.0% | -2176.4% | -3679.9% | -1994.3% | -2054.2% | -2673.7% | -44496.4% |
| Net margin | — | — | -5988.1% | -653.8% | -2137.7% | -3677.9% | -1808.7% | -1462.8% | -2258.1% | -7461.7% |
Balance sheet
Fiscal years, from Helius Medical Technologies's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $3M | $6M | $26M | $5M | $3M | $11M | $15M | $5M | $1M | $7M |
| Receivables | $399,106 | $704,000 | $177,000 | $210,000 | $74,000 | $66,000 | $71,000 | $117,000 | $70,000 | — |
| Inventory | — | — | $392,000 | $598,000 | $389,000 | $476,000 | $589,000 | $457,000 | $1M | $1M |
| Total current assets | $4M | $7M | $27M | $7M | $5M | $13M | $17M | $7M | $3M | $31M |
| Property, plant and equipment | — | $173,000 | $554,000 | $712,000 | $486,000 | $409,000 | $347,000 | $178,000 | $107,000 | — |
| Goodwill | — | — | — | $1M | $759,000 | $763,000 | — | — | — | — |
| Total assets | $4M | $7M | $28M | $10M | $7M | $14M | $17M | $8M | $4M | $304M |
| Total current liabilities | $4M | $14M | $18M | $4M | $2M | $3M | $2M | $2M | $2M | $3M |
| Total liabilities | $4M | $14M | $18M | $5M | $3M | $3M | $9M | $5M | $2M | $3M |
| Shareholders' equity | -$15,000 | -$7M | $10M | $6M | $4M | $11M | $8M | $2M | $1M | $301M |
| Net debt | -$3M | -$6M | -$26M | -$5M | -$3M | -$11M | -$15M | -$5M | -$1M | -$7M |
Cash flow
Fiscal years, from Helius Medical Technologies's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8M | -$19M | -$20M | -$21M | -$12M | -$13M | -$14M | -$10M | -$11M | -$17M |
| Capital spending | — | $190,000 | $440,000 | $353,000 | $70,000 | $56,000 | $17,000 | $29,000 | $5,000 | — |
| Free cash flow | — | -$20M | -$20M | -$21M | -$12M | -$13M | -$14M | -$10M | -$11M | — |
| Stock-based compensation | $1M | $2M | $8M | $5M | $3M | $4M | $2M | $2M | $3M | $9M |
| Free cash flow margin | — | — | -4196.9% | -1427.3% | -1786.4% | -2727.0% | -1841.5% | -1726.4% | -2124.2% | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HSDT.
Open HSDT in InvestinglyQuestions
What was Helius Medical Technologies's revenue in 2025?
$548,000 in fiscal 2025, from its 10-K filing.
From Helius Medical Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.